These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 34314701)

  • 1. ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids.
    Bowles KR; Silva MC; Whitney K; Bertucci T; Berlind JE; Lai JD; Garza JC; Boles NC; Mahali S; Strang KH; Marsh JA; Chen C; Pugh DA; Liu Y; Gordon RE; Goderie SK; Chowdhury R; Lotz S; Lane K; Crary JF; Haggarty SJ; Karch CM; Ichida JK; Goate AM; Temple S
    Cell; 2021 Aug; 184(17):4547-4563.e17. PubMed ID: 34314701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to caspase-mediated cleavage of tau and apoptotic cell death.
    Theofilas P; Wang C; Butler D; Morales DO; Petersen C; Ambrose A; Chin B; Yang T; Khan S; Ng R; Kayed R; Karch CM; Miller BL; Gestwicki JE; Gan L; Temple S; Arkin MR; Grinberg LT
    Mol Cell Neurosci; 2024 Sep; 130():103954. PubMed ID: 39032719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.
    Sposito T; Preza E; Mahoney CJ; Setó-Salvia N; Ryan NS; Morris HR; Arber C; Devine MJ; Houlden H; Warner TT; Bushell TJ; Zagnoni M; Kunath T; Livesey FJ; Fox NC; Rossor MN; Hardy J; Wray S
    Hum Mol Genet; 2015 Sep; 24(18):5260-9. PubMed ID: 26136155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tau mutations in cerebral organoids induce a progressive dyshomeostasis of cholesterol.
    Glasauer SMK; Goderie SK; Rauch JN; Guzman E; Audouard M; Bertucci T; Joy S; Rommelfanger E; Luna G; Keane-Rivera E; Lotz S; Borden S; Armando AM; Quehenberger O; Temple S; Kosik KS
    Stem Cell Reports; 2022 Sep; 17(9):2127-2140. PubMed ID: 35985329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy.
    Cheng C; Reis SA; Adams ET; Fass DM; Angus SP; Stuhlmiller TJ; Richardson J; Olafson H; Wang ET; Patnaik D; Beauchamp RL; Feldman DA; Silva MC; Sur M; Johnson GL; Ramesh V; Miller BL; Temple S; Kosik KS; Dickerson BC; Haggarty SJ
    Sci Rep; 2021 Aug; 11(1):17029. PubMed ID: 34426604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia.
    Kopach O; Esteras N; Wray S; Abramov AY; Rusakov DA
    Cell Death Dis; 2021 Jul; 12(8):716. PubMed ID: 34274950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability.
    Silva MC; Cheng C; Mair W; Almeida S; Fong H; Biswas MHU; Zhang Z; Huang Y; Temple S; Coppola G; Geschwind DH; Karydas A; Miller BL; Kosik KS; Gao FB; Steen JA; Haggarty SJ
    Stem Cell Reports; 2016 Sep; 7(3):325-340. PubMed ID: 27594585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
    Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
    Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD.
    Korn L; Speicher AM; Schroeter CB; Gola L; Kaehne T; Engler A; Disse P; Fernández-Orth J; Csatári J; Naumann M; Seebohm G; Meuth SG; Schöler HR; Wiendl H; Kovac S; Pawlowski M
    Redox Biol; 2023 Feb; 59():102597. PubMed ID: 36599286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model.
    Pir GJ; Choudhary B; Mandelkow E; Mandelkow EM
    Mol Neurodegener; 2016 Apr; 11():33. PubMed ID: 27118310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs.
    Nakamura M; Shiozawa S; Tsuboi D; Amano M; Watanabe H; Maeda S; Kimura T; Yoshimatsu S; Kisa F; Karch CM; Miyasaka T; Takashima A; Sahara N; Hisanaga SI; Ikeuchi T; Kaibuchi K; Okano H
    Stem Cell Reports; 2019 Oct; 13(4):684-699. PubMed ID: 31543469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP.
    Jiang S; Wen N; Li Z; Dube U; Del Aguila J; Budde J; Martinez R; Hsu S; Fernandez MV; Cairns NJ; ; ; Harari O; Cruchaga C; Karch CM
    Transl Psychiatry; 2018 Dec; 8(1):265. PubMed ID: 30546007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.
    Biswas MHU; Almeida S; Lopez-Gonzalez R; Mao W; Zhang Z; Karydas A; Geschwind MD; Biernat J; Mandelkow EM; Futai K; Miller BL; Gao FB
    Stem Cell Reports; 2016 Sep; 7(3):316-324. PubMed ID: 27594586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
    Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
    Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4R tau drives endolysosomal and autophagy dysfunction in frontotemporal dementia.
    Hung C; Patani R
    Autophagy; 2024 May; 20(5):1201-1202. PubMed ID: 38174587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells.
    Lines G; Casey JM; Preza E; Wray S
    Mol Cell Neurosci; 2020 Dec; 109():103553. PubMed ID: 32956830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration.
    Mahali S; Martinez R; King M; Verbeck A; Harari O; Benitez BA; Horie K; Sato C; Temple S; Karch CM
    Transl Psychiatry; 2022 Dec; 12(1):508. PubMed ID: 36494352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling neurodegeneration with mutant-tau organoids.
    Pellegrini L; Lancaster MA
    Cell; 2021 Aug; 184(17):4377-4379. PubMed ID: 34416145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau inhibits mitochondrial calcium efflux and makes neurons vulnerable to calcium-induced cell death.
    Britti E; Ros J; Esteras N; Abramov AY
    Cell Calcium; 2020 Mar; 86():102150. PubMed ID: 31918031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAG3 and SYNPO (synaptopodin) facilitate phospho-MAPT/Tau degradation via autophagy in neuronal processes.
    Ji C; Tang M; Zeidler C; Höhfeld J; Johnson GV
    Autophagy; 2019 Jul; 15(7):1199-1213. PubMed ID: 30744518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.